skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Iron Sucrose Injection (Code C60883)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Iron Sucrose Injection

Definition: A sterile aqueous complex of polynuclear iron (III)-hydroxide in sucrose for intravenous use. Following intravenous administration, iron sucrose is dissociated by the reticuloendothelial system into iron and sucrose; the sucrose component is eliminated mainly by urinary excretion. Iron sucrose can be administered with or without erythropoietin to raise hemoglobin levels and may be used in cases of oral iron therapy intolerance or ineffectiveness. Hypersensitivity reactions are less common with iron sucrose compared to other parenteral iron products, such as iron dextran.

Label: Iron Sucrose Injection

NCI Thesaurus Code: C60883 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0529374  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Ferric Hydroxide Saccharate Injection
Intravenous Ferric Hydroxide Saccharate
Iron Saccharate Injection
Iron Sucrose for Injection
Iron Sucrose Injection

External Source Codes: 
PDQ Closed Trial Search ID 467930
PDQ Open Trial Search ID 467930 (check for NCI PDQ open clinical trial info)
UMLS CUI C0529374

Other Properties:
     Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For Treatment of iron deficiency for both dialysis and non-dialysis patients with kidney disease, with or without concurrent erythropoietin therapy.
code C60883
Legacy_Concept_Name Iron_Sucrose_Injection
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom